(S (NP-SBJ (NP (JJ USF-related) (NN transcription) (NN factor)) (, ,) (NP (NN HIV-TF1)) (, ,)) (VP (VBZ stimulates) (NP (NP (NN transcription)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus-1))))) (. .))
(S (NP-SBJ-28 (NP (DT The) (NN transcription) (NN factor) (NN HIV-TF1)) (, ,) (SBAR (WHNP-27 (WDT which)) (S (NP-SBJ (-NONE- *T*-27)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT a) (NN region)) (ADJP (NP (QP (IN about) (CD 60)) (NN bp)) (JJ upstream) (PP (IN from) (NP (NP (DT the) (NN enhancer)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus-1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-)))))))))))) (, ,)) (VP (VBD was) (VP (VBN purified) (NP (-NONE- *-28)) (PP (IN from) (NP (JJ human) (NN B) (NNS cells))))) (. .))
(S (NP-SBJ (NN HIV-TF1)) (VP (VBD had) (NP (NP (DT a) (JJ molecular) (NN weight)) (PP (IN of) (NP (CD 39,000))))) (. .))
(S (NP-SBJ (NP (NN Binding)) (PP (IN of) (NP (NN HIV-TF1))) (PP (TO to) (NP (DT the) (NN HIV) (NP (NP (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-)))))) (VP (VBD activated) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN HIV) (NN promoter)))) (ADVP (FW in) (FW vitro))) (. .))
(S (NP-SBJ (NP (DT The) (JJ HIV-TF1-binding) (NN site)) (PP (IN in) (NP (NN HIV) (NN LTR)))) (VP (VBD was) (ADJP-PRD (JJ similar) (PP (TO to) (NP (NP (DT the) (NN site)) (VP (VBN recognized) (NP (-NONE- *)) (PP (IN by) (NP (NP (NP (JJ upstream) (JJ stimulatory) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN USF)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN adenovirus) (JJ major) (JJ late) (NN promoter)))))))))) (. .))
(S (NP-SBJ (NP (JJ DNA-binding) (NNS properties)) (PP (IN of) (NP (NN HIV-TF1)))) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NN HIV-TF1)) (VP (MD might) (VP (VB be) (ADJP-PRD (ADJP-COOD (ADJP (JJ identical) (PP (-NONE- *RNR*-29))) (CC or) (ADJP (JJ related) (PP (-NONE- *RNR*-29)))) (PP-29 (TO to) (NP (NN USF))))))))) (. .))
(S (ADVP (RB Interestingly)) (, ,) (NP-SBJ (NP (NN treatment)) (PP (IN of) (NP (VBN purified) (NN HIV-TF1))) (PP (IN by) (NP (NN phosphatase)))) (ADVP (RB greatly)) (VP (VBD reduced) (NP (PRP$ its) (JJ DNA-binding) (NN activity)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (NN phosphorylation)) (PP (IN of) (NP (NN HIV-TF1)))) (VP (VBD was) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NN DNA) (NN binding)))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN disruption)) (PP (IN of) (NP (JJ HIV-TF1-binding) (NN site)))) (VP (VBD induced) (NP (NP (DT a) (NP (CD 60) (NN %)) (NP (NN decrease))) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN HIV) (NN promoter)))))))) (ADVP (FW in) (FW vivo))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-100 (NN HIV-TF1)) (VP (VBZ is) (VP (VBN involved) (NP (-NONE- *-100)) (PP (IN in) (NP (NP (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NN HIV-1)))))))))) (. .))
